Advanced Search
Submit ManuscriptADVANCE ONLINE PUBLICATION
Mitochondrial PD-L1 modulates cancer immunotherapy
Xiaoming Dai1,† , Jing Liu1,† , Wenyi Wei1,*
1Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USAThe expression and subcellular localization of immune checkpoint protein PD-L1 have been implicated to play an important role in cancer immunotherapy. In a recent paper published in Cell Research, Xie et al. report that promoting mitochondrial distribution of PD-L1 through targeting the ATAD3A-PINK1-mitophagy axis is a promising strategy to overcome chemoimmunotherapy resistance.
https://doi.org/10.1038/s41422-023-00777-4